[KYMR] QoQ Quarter Result on 31-Dec-2021 [#Q4]

Stock
[KYMR] Kymera Therapeutics, Inc.
Announcement Date
24-Feb-2022
Financial Year
2021
Quarter
31-Dec-2021 [#Q4]
Profit Trend
QoQ- -18.61%
YoY- -167.25%
Quarter Report
KYMR's Result
KYMR's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Revenue 9,551 11,514 9,622 15,275 20,336 18,519 18,702 -36.08%
PBT -43,002 -40,257 -36,684 -33,901 -28,582 -24,660 -13,075 120.99%
Tax 1,916 -553 -249 51 125 98 118 540.13%
NP -43,002 -39,704 -36,435 -33,901 -28,582 -24,660 -13,075 120.99%
Tax Rate - - - - - - - -
Total Cost 52,553 51,218 46,057 49,176 48,918 43,179 31,777 39.80%
Ratio Analysis
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
NP Margin -450.24 -344.83 -378.66 -221.94 -140.55 -133.16 -69.91 245.76%
Per Share
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
EPS -0.79 -0.77 -0.71 -0.66 -0.56 -0.55 -0.29 94.93%
EPS Diluted -0.79 -0.77 -0.71 -0.66 -0.56 -0.55 -0.29 94.93%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.